Filing Details
- Accession Number:
- 0001127602-12-022204
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-07-13 17:13:05
- Reporting Period:
- 2012-07-12
- Filing Date:
- 2012-07-13
- Accepted Time:
- 2012-07-13 16:13:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1022079 | Quest Diagnostics Inc | DGX | Services-Medical Laboratories (8071) | 161387862 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1221534 | Daniel Stanzione | C/O Quest Diagnostics Incorporated 3 Giralda Farms Madison NJ 07940 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-07-12 | 10,000 | $55.40 | 30,176 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-07-12 | 20,000 | $30.46 | 50,176 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-07-12 | 30,000 | $62.00 | 20,176 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2012-07-12 | 10,000 | $0.00 | 10,000 | $55.40 |
| Common Stock | Stock Options (Right to Buy) | Disposition | 2012-07-12 | 20,000 | $0.00 | 20,000 | $30.46 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2013-05-04 | No | 4 | M | Direct | |
| 0 | 2013-05-13 | No | 4 | M | Direct |
Footnotes
- The exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 16, 2012.
- The options vested in three equal annual installments beginning with the first on May 4, 2007, the second on May 4, 2008 and the final on May 4, 2009.
- The options vested in three equal annual installments beginning with the first on May 13, 2004, the second on May 13, 2005 and the final on May 13, 2006.
Billionaire Hedge Funds
